CG
ONC

Colony Group’s BeOne Medicines Ltd ONC Stock Holding History

Colony Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$1.83M Hold
10,188
– – 0.03% 347
2023
Q2 		$1.82M Buy
10,188
+1
+0% +$230 0.03% 359
2023
Q1 		$2.2M Hold
10,187
– – 0.03% 330
2022
Q4 		$2.24M Hold
10,187
– – 0.03% 355
2022
Q3 		$1.37M Buy
+10,187
New +$1.75M 0.02% 388

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Colony Group's ONC Position: Q3 2023 in Review

Colony Group held its BeOne Medicines Ltd (ONC) position steady in Q3 2023 at 10,188 shares worth $1.83M. The position accounts for 0.03% of the portfolio, ranked #347.

Colony Group first reported a position in ONC in Q3 2022 and has held it in 5 quarters since. The position peaked at $2.24M in Q4 2022. 201 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

  • Colony Group held 10,188 shares of BeOne Medicines Ltd worth $1.83M as of Q3 2023.
  • Colony Group left its BeOne Medicines Ltd share count unchanged in Q3 2023.
  • BeOne Medicines Ltd made up 0.03% of Colony Group's portfolio in Q3 2023, its #347 holding.
  • Colony Group first reported a position in BeOne Medicines Ltd in Q3 2022 and has held it in 5 quarters since.
  • Colony Group's BeOne Medicines Ltd position peaked at $2.24M in Q4 2022.
  • 201 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on Colony Group's 13F filing for Q3 2023, filed 14 Nov 2023.